Physician profile
Michael E Kirkpatrick
NPI 1871517862
$789.73
in general payments reported to CMS, 2019-2025
18 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2021: $13.83 · 2023: $35.03 · 2024: $128 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.64 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $140.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $128.40 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $65.06 | 2019 | |
| Abbvie INC. | $45.62 | 2021-2025 | |
| Amgen INC. | $37.28 | 2019-2023 | Otezla, Repatha |
| Abbott Laboratories | $25.23 | 2025 | Freestyle Libre 2 |
| Optinose US, INC. | $25.02 | 2024 | |
| Lilly USA, LLC | $24.07 | 2019 | |
| Irhythm Technologies, INC. | $22.47 | 2019 | |
| Glaxosmithkline, LLC. | $18.36 | 2025 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $16.02 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.30 | 2019 | |
| Ge Healthcare | $14.90 | 2019 | |
| Genentech USA, INC. | $14.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.82 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.